D-341-2014 Class III Terminated
FDA drug recall D-341-2014 was initiated by Sandoz Inc on Nov 6, 2013 and is designated Class III. Reason for recall: Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions. The recall status is terminated (terminated May 29, 2014). Affected quantity: 11,496 bottles (100 count) and 62 bottles (500 count).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2013
- Initiation Date
- Nov 6, 2013
- Termination Date
- May 29, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,496 bottles (100 count) and 62 bottles (500 count)
Product description
Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05
Reason for recall
Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.
Distribution pattern
Nationwide
Code information
Lot #: a) CU6131, b) CW1161
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-341-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026